Conexeu Sciences Inc. Common Stock (CNXU)

US · Healthcare · Biotechnology

$3.06-22.53%

Last close · 2026-10-16

Latest quarter · ended 2026-07-31

Revenue

Net profit

$-7.7M

EPS

$-0.29

EPS estimate

$-0.10

EPS came in at -0.29 against a street estimate of -0.10 — a miss of 190.0%.

Market cap

$93.4M

Forward P/E

0.0

P/B

20.13

Book value

$0.21

EPS (TTM)

$-0.61

52-week high

$18.79

52-week low

$3.05

50-day MA

$5.92

200-day MA

$8.61

Analysts rate Conexeu Sciences Inc. Common Stock a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $20.00.

Insiders

52.06%

Institutions

7.59%

Fund	Stake
UBS Group AG	0.04%
Morgan Stanley - Brokerage Accounts	0.02%
Citigroup Inc	0.02%
Hollencrest Securities, LLC	0.00%
Royal Bank of Canada	0.00%
Mercer Global Advisors Inc.	0.00%
Integrated Wealth Concepts LLC	0.00%
JONES FINANCIAL COMPANIES LLLP	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Conexeu Sciences Inc. Common Stock — free to start.

Data updated 2026-10-18.